Sign Out
Mometasone furoate (Momeclir) Nasal spray suspension is indicated for use in adults and children 2 years of age and older to treat the symptoms of seasonal allergic or perennial rhinitis. In patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis, prophylactic treatment with Mometasone furoate (Momeclir) Nasal spray suspension may be initiated up to four weeks prior to the anticipated start of the pollen season.
Mometasone furoate (Momeclir) Nasal spray suspension is indicated for the treatment of nasal polyps in adults 18 years of age and older.
Mometasone furoate (Momeclir) Nasal spray suspension is indicated for the treatment of acute rhinosinusitis without severe bacterial infection in adults and children 12 years of age and older.
Continue with Google